Semler Scientific (SMLR) Set to Announce Quarterly Earnings on Monday

Semler Scientific (NASDAQ:SMLR) is scheduled to post its quarterly earnings results after the market closes on Monday, November 4th. Investors that wish to register for the company’s conference call can do so using this link.

Semler Scientific (NASDAQ:SMLR) last announced its earnings results on Monday, August 5th. The company reported $0.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.56 by $0.08. Semler Scientific had a net margin of 25.62% and a return on equity of 21.17%. The company had revenue of $14.47 million during the quarter.

Semler Scientific Stock Performance

NASDAQ:SMLR opened at $27.42 on Monday. Semler Scientific has a 52 week low of $20.88 and a 52 week high of $53.38. The firm’s 50-day simple moving average is $25.74 and its 200 day simple moving average is $28.46. The firm has a market cap of $191.67 million, a price-to-earnings ratio of 13.44 and a beta of 0.96.

Insiders Place Their Bets

In other news, CEO Douglas Murphy-Chutorian sold 10,000 shares of Semler Scientific stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $28.35, for a total value of $283,500.00. Following the completion of the sale, the chief executive officer now directly owns 60,220 shares in the company, valued at approximately $1,707,237. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 30.20% of the company’s stock.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.